19filings we hold
10topics disclosed
Instruments and medical devicesindustry
OHbased in
Across 19 filings we hold,
INVACARE CORP has written down 10 of the topics we track. That places it 10 of 34 companies we hold in instruments and medical devices, by how much we have collected.
INVACARE CORP has written 10 of our tracked topics into its filings. What it disclosed is public. What that now obligates is not, and it is 651 controls.From SEC filings and our framework corpus
What it discloses
Tracked topics appearing in this company's filings, most frequent first. Each opens
the topic, where you can see who else files it and what it obligates.
What this obligates
Every instrument below governs something INVACARE CORP has written into a filing. This maps to obligations within those frameworks. It is not a finding that the company has failed any of them, and nothing here establishes noncompliance.
10 frameworks, 651 controls between them, deduplicated across topics.
And what those same controls reach into
The controls behind those frameworks also appear in the instruments below, which suggests increased attention to them follows from the same work rather than from a separate programme.
ISO 27701:2019839
ISO 27002:2022636
ISO/IEC 42001:2023353
PCI DSS 4.0214
NIS2 Directive201
COBIT 2019148
Tell me when INVACARE CORP files something new
One email when there is a new SEC filing, naming what it is and what our corpus says it puts in scope. Nothing else, and one click to stop.
When it filed
Filings we hold, by year. Hover a bar for the count. Peak 7 in 2022.
Recent filings
| Filed | Form | Item | |
|---|
| 2024-04-10 | 8-K | Entry into a material agreement, Item 2.03, Item 2.05 | filing |
| 2023-05-15 | 8-K | Results of operations, the earnings release, Financial statements and exhibits | filing |
| 2023-04-03 | 8-K | Regulation FD disclosure, Financial statements and exhibits | filing |
| 2023-02-01 | 8-K | Entry into a material agreement, Item 1.02, Bankruptcy or receivership | filing |
| 2022-12-27 | 8-K | Entry into a material agreement, Item 2.03, Regulation FD disclosure | filing |
| 2022-12-09 | 8-K | Director or officer departure, Financial statements and exhibits | filing |
| 2022-11-21 | 8-K | Entry into a material agreement, Director or officer departure, Regulation FD disclosure | filing |
| 2022-11-07 | 8-K | Results of operations, the earnings release, Financial statements and exhibits | filing |
| 2022-10-03 | 8-K | Item 3.02, Regulation FD disclosure, Other material event | filing |
| 2022-07-26 | 8-K | Entry into a material agreement, Item 2.03, Item 3.02 | filing |
| 2022-03-09 | 10-K | | filing |
| 2021-03-16 | 8-K | Entry into a material agreement, Item 2.03, Item 3.02 | filing |
Others in instruments and medical devices
The companies we hold most on in the same industry classification. Each opens side by
side with this one.
What this page is
Every row comes from SEC full-text search over this company's filings, matched against the
compliance and risk phrases we track. It is a record of what the company itself wrote down, in
documents it is legally accountable for. It is not an assessment of the company, a rating, or
a claim about how well it manages anything.
A phrase appearing in a filing frequently means the risk section
mentions it, not that an event occurred. Where an item number indicates an actual event, the
Item column says so.
All of
instruments and medical devices · All companies ·
Today's edition